Retrospective Study demonstrates clinical efficacy and statistical support for tissue processed via BioREtain to care for treatment-resistant chronic wounds Study published in the peer-reviewed journal, ‘International Wound Journal’ POMPANO BEACH, Fla., Oct. 17, 2024 – PRISM MediaWire – BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of … Continue reading “BioStem Technologies Reports Breakthrough Results in a Diabetic Foot Ulcer Wound Closure Study Comparing BioREtain® to Standard of Care Treatment”
Author: Sophia Vida
Oncocyte Announces Participation in the LD Micro Main Event XVII Conference in Los Angeles
IRVINE, Calif., Oct. 16, 2024 – PRISM MediaWire – Oncocyte Corp. (NASDAQ: OCX), a diagnostics technology company,…
SKYX Announces a Collaboration with Wayfair for its Advanced and Smart Plug & Play Lighting for Retail and Professional Segments including Designers and Architects
SKYX will Offer a Variety of its Advanced and Smart Plug & Play Lighting and…
Join the Biofuels Brazil Forum 2024!
Biofuels Brazil Forum 2024 Join the Biofuels Brazil Forum 2024! New York, October 15, 2024…
The 10th World Battery & Energy Storage Industry Expo (WBE 2025)
The 10th World Battery & Energy Storage Industry Expo (WBE 2025) Date: August 8th-10th, 2025…
4VITAHEALTH Launches Groundbreaking Mental Health Supplements
Tucson, Arizona, October 15, 2024 – PRISM MediaWire – 4VITAHEALTH, a pioneering mental health and…
BioStem Technologies Establishes National Pricing for Vendaje AC® from the Center for Medicare Services and Provides Reimbursement in All MAC Regions
Vendaje AC to launch across MAC regions nationwide through Venture Medical, the Company’s exclusive sales…
Sono-Tek Reports Fiscal Second Quarter and First Half 2025 Financial Results, Record Backlog and Provides Revenue Guidance
Q2 Sequential Revenue Growth Meets Quarterly Guidance of 2%-5% Record Equipment and Service Backlog of…
Co-Founder of Shire Pharmaceuticals Appointed as Chief Operating Officer of Klotho Neurosciences
KLTO strengthens team with industry veteran and is poised to accelerate the development of its…
Lipella Pharmaceuticals Announces U.S. Patent Allowance for Innovative Liposomal Drug Delivery Platform
Patent application covers key technology innovations for delivering therapeutic agents Proprietary technology enables precise delivery…
SPZI: JP 3E Holdings, Inc. Accelerates Growth with Major Corporate Milestones Toward Uplisting
NEW YORK, October 14, 2024 – PRISM MediaWire – JP 3E Holdings, Inc. (OTC: SPZI),…
In Light of World Mental Health Day, PRISM Highlights Mental Health Index Companies Making a Difference
New York, New York, October 10, 2024 – PRISM MediaWire – PRISM MediaWire – Mental…
Lipella Pharmaceuticals to Present at 2024 Maxim Healthcare Virtual Summit
PITTSBURGH, Oct. 09, 2024 – PRISM MediaWire – Lipella Pharmaceuticals, Inc. (Nasdaq: LIPO) (“Lipella” or…
SKYX Provides Corporate Update, including Significant Insider Buying
MIAMI, Oct. 09, 2024 – PRISM MediaWire – SKYX (NASDAQ: SKYX) (d/b/a “SKYX Technologies”), a…
